Company / PP&E per Share
Summit Therapeutics Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
+291.3%
vs FY2024
Sector context
#184 of 191
Health Care
What the data says
PP&E per Share changed +291% YoY in FY2025, a notable deviation from the 6-year average annual change of +62%.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -33.4%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -46.5%
- 5-Year CAGR
- -33.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 291.3% year-over-year.
- Ranks #184 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +291.3% |
| FY2024 | $0.00 | -62.5% |
| FY2023 | $0.00 | -89.5% |
| FY2022 | $0.01 | +347.6% |
| FY2021 | $0.00 | -80.9% |
| FY2020 | $0.01 | -31.6% |
| FY2019 | $0.02 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026